Sponsors (4)
The bill strengthens privacy and control for individuals whose genetic data appears in bankruptcy estates, but does so at the cost of added administrative burden, possible delays or reduced recoveries for estates and creditors, and some residual risks and legal uncertainty during implementation.
People whose genetic data is held in bankruptcy estates will receive required prior written notice before any sale, use, or lease of their genomic information, giving them greater control over highly sensitive personal data.
Patients and other individuals' genomic information that is not sold must be deleted by trustees/courts, reducing the amount of retained sensitive data and lowering long‑term risk of breaches or misuse.
Trustees, purchasers, and courts get clearer statutory rules about handling genetic data in bankruptcy, reducing legal uncertainty for estate administrators and potential buyers.
Creditors and estate administrators may face delays or blocked sales of assets that include genetic data because of the notice/consent process, prolonging bankruptcy proceedings and increasing administrative expenses.
Trustees and estates will incur administrative costs to provide individual notices and carry out deletions, potentially reducing recoveries available to creditors and increasing costs borne by estates (and indirectly taxpayers in some cases).
Sensitive genetic information could still be exposed during estate administration before deletion, and inconsistent court standards across districts could leave some data inadequately protected.
Based on analysis of 2 sections of legislative text.
Requires notice and deletion safeguards for genetic information in bankruptcy estates and bars sale/use/lease without prior written notice and court findings.
Official title: To amend title 11, United States Code, to account for the protection of genetic information in bankruptcy.
Introduced July 17, 2025 by Benjamin Cline · Last progress July 17, 2025
Adds legal protections for genetic information in bankruptcy cases by treating genetic information as a protected category of personal data. Trustees and debtors-in-possession must give actual prior written notice to affected persons before selling, leasing, or using genetic information from the bankruptcy estate and must delete genetic information remaining in the estate unless it was lawfully disposed of under bankruptcy sale rules. The rules apply on enactment to pending, commenced, or reopened Title 11 cases.